Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2013
ISBN 10: 3659404691 ISBN 13: 9783659404696
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
Lingua: Inglese
Editore: Lap Lambert Academic Publishing, 2013
ISBN 10: 3659404691 ISBN 13: 9783659404696
Da: Revaluation Books, Exeter, Regno Unito
EUR 125,99
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 156 pages. 8.66x5.91x0.36 inches. In Stock.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Jun 2013, 2013
ISBN 10: 3659404691 ISBN 13: 9783659404696
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 61,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Oral route is preferred for the treatment of various diseases/disorders. However, the oral bioavailability of nearly 40% of newly discovered molecules is diminished due to various physicochemical and physiological barriers. The reasons of low and variable oral bioavailability include, high lipophilicity, restricted permeability, first pass metabolism in the gut and liver and efflux transporter systems. These problems, in turn, lead to high intra- and inter-subject variability and lack of dose proportionality. To overcome these drawbacks, various formulation strategies have been adopted. However, the focus has recently shifted to lipid-based formulations owing to their ability to improve the oral bioavailability of poorly water soluble drug compounds. In this regard, self-emulsifying drug delivery systems (SEDDS), particularly nano-based systems, have been able to surmount the above mentioned problems. SEDDS are the recent technological innovations which are physically more stable and easier to manufacture with the globule size ranging between 10 to 1000 nm. Not only this, SEDDS are able to modulate the drug absorption leading ultimately to enhance oral bioavailability. 156 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2013
ISBN 10: 3659404691 ISBN 13: 9783659404696
Da: moluna, Greven, Germania
EUR 50,66
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Bandyopadhyay ShantanuShantanu Bandyopadhyay, M.Pharm, has recently submitted his doctoral research to Panjab University, Chandigarh, India. He has contributed in 13 research and review publications, 1 book review, 4 book chapters an.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2013
ISBN 10: 3659404691 ISBN 13: 9783659404696
Da: Majestic Books, Hounslow, Regno Unito
EUR 96,65
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2013
ISBN 10: 3659404691 ISBN 13: 9783659404696
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 98,64
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Jun 2013, 2013
ISBN 10: 3659404691 ISBN 13: 9783659404696
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 61,90
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Oral route is preferred for the treatment of various diseases/disorders. However, the oral bioavailability of nearly 40% of newly discovered molecules is diminished due to various physicochemical and physiological barriers. The reasons of low and variable oral bioavailability include, high lipophilicity, restricted permeability, first pass metabolism in the gut and liver and efflux transporter systems. These problems, in turn, lead to high intra- and inter-subject variability and lack of dose proportionality. To overcome these drawbacks, various formulation strategies have been adopted. However, the focus has recently shifted to lipid-based formulations owing to their ability to improve the oral bioavailability of poorly water soluble drug compounds. In this regard, self-emulsifying drug delivery systems (SEDDS), particularly nano-based systems, have been able to surmount the above mentioned problems. SEDDS are the recent technological innovations which are physically more stable and easier to manufacture with the globule size ranging between 10 to 1000 nm. Not only this, SEDDS are able to modulate the drug absorption leading ultimately to enhance oral bioavailability.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 156 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2013
ISBN 10: 3659404691 ISBN 13: 9783659404696
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 61,90
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Oral route is preferred for the treatment of various diseases/disorders. However, the oral bioavailability of nearly 40% of newly discovered molecules is diminished due to various physicochemical and physiological barriers. The reasons of low and variable oral bioavailability include, high lipophilicity, restricted permeability, first pass metabolism in the gut and liver and efflux transporter systems. These problems, in turn, lead to high intra- and inter-subject variability and lack of dose proportionality. To overcome these drawbacks, various formulation strategies have been adopted. However, the focus has recently shifted to lipid-based formulations owing to their ability to improve the oral bioavailability of poorly water soluble drug compounds. In this regard, self-emulsifying drug delivery systems (SEDDS), particularly nano-based systems, have been able to surmount the above mentioned problems. SEDDS are the recent technological innovations which are physically more stable and easier to manufacture with the globule size ranging between 10 to 1000 nm. Not only this, SEDDS are able to modulate the drug absorption leading ultimately to enhance oral bioavailability.